PDCD1 and neoplasm: Moreover, LAG-3 expression is strongly correlated with the programmed cell death protein 1 gene (pdcd1) in papillary RCC, suggesting that co-targeted immunotherapy with PD-1 may induce a potent synergistic anti-tumor effect [44,85].